Section 3397-C. Antonio G

Olivieri  controlled  substances  therapeutic
  research program established; participation.  1. The Antonio G. Olivieri
  controlled substances therapeutic research program is hereby established
  in the department of health. The commissioner shall promulgate rules and
  regulations necessary for the proper administration  of  the  controlled
  substances   therapeutic   research   act.  In  such  promulgation,  the
  commissioner shall take into consideration  those  pertinent  rules  and
  regulations promulgated by the drug enforcement administration, food and
  drug administration and the national institute on drug abuse.
    2.  Participation  in  the  Antonio  G. Olivieri controlled substances
  therapeutic research  program  shall  be  limited  to  cancer  patients,
  glaucoma  patients  and  patients  afflicted with other diseases as such
  diseases are  approved  by  the  commissioner.  Such  patient  shall  be
  certified  by  a  physician  to  and approved by a patient qualification
  review board or committee  in  the  manner  provided  by  this  article.
  Physician certification and board or committee approval shall be limited
  to   such   patients   who   are   involved  in  a  life-threatening  or
  sense-threatening situation.  Patients  seeking  participation  in  such
  program  may  seek  the  advice  and  shall be entitled to be advised by
  appropriate  medical  personnel  concerning  the  medical  efficacy   of
  treatment with conventional controlled substances.
    3.  The  commissioner, on behalf of the department, shall apply to the
  food and drug administration for  an  investigational  new  drug  permit
  within ninety days after the effective date of this section.